These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25664147)

  • 1. Benefits and risks of sugammadex.
    Park JY
    Korean J Anesthesiol; 2015 Feb; 68(1):1-2. PubMed ID: 25664147
    [No Abstract]   [Full Text] [Related]  

  • 2. Sugammadex: a novel selective relaxant binding agent.
    Naguib M; Brull SJ
    Expert Rev Clin Pharmacol; 2009 Jan; 2(1):37-53. PubMed ID: 24422770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the effect of sugammadex always rapid in onset?
    Van Gestel L; Cammu G
    Acta Anaesthesiol Belg; 2013; 64(2):41-7. PubMed ID: 24191525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is sugammadex economically viable for routine use.
    Fuchs-Buder T; Meistelman C; Schreiber JU
    Curr Opin Anaesthesiol; 2012 Apr; 25(2):217-20. PubMed ID: 22157200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Sugammadex on Progesterone Levels in Pregnant Rats.
    Et T; Topal A; Erol A; Tavlan A; Kılıçaslan A; Uzun ST
    Balkan Med J; 2015 Apr; 32(2):203-7. PubMed ID: 26167346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological evaluation of the effect of sugammadex on hemostasis and bleeding.
    Raft J; Guerci P; Harter V; Fuchs-Buder T; Meistelman C
    Korean J Anesthesiol; 2015 Feb; 68(1):17-21. PubMed ID: 25664150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade.
    Cheong SH; Ki S; Lee J; Lee JH; Kim MH; Hur D; Cho K; Lim SH; Lee KM; Kim YJ; Lee W
    Korean J Anesthesiol; 2015 Dec; 68(6):547-55. PubMed ID: 26634077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effects of intra-arterial sugammadex and dexmedetomidine: an experimental study].
    Hancı V; Özbilgin Ş; Özbal S; Kamacı G; Ateş H; Boztaş N; Ergür BU; Arıkanoğlu A; Yılmaz O; Yurtlu BS
    Rev Bras Anestesiol; 2016; 66(5):456-64. PubMed ID: 27424737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade.
    Kim KS; Oh YN; Kim TY; Oh SY; Sin YH
    Korean J Anesthesiol; 2016 Jun; 69(3):239-43. PubMed ID: 27274368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effectiveness of sugammadex for verapamil intoxication.
    Ozbilgin S; Ozbilgin M; Kucukoztas B; Kamaci G; Unek T; Yurtlu BS; Güneli ME; Hanci V; Gunerli A
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):280-5. PubMed ID: 23724791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade.
    Schaller SJ; Lewald H
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1097-108. PubMed ID: 27463265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sugammadex and rocuronium mast cell number and degranulation in rat liver.
    Tomak Y; Yılmaz A; Bostan H; Tümkaya L; Altuner D; Kalkan Y; Erdivanlı B
    Anaesthesia; 2012 Oct; 67(10):1101-4. PubMed ID: 22827538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of sugammadex.
    Caldwell JE; Miller RD
    Anaesthesia; 2009 Mar; 64 Suppl 1():66-72. PubMed ID: 19222433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three suspected cases of sugammadex-induced anaphylactic shock.
    Takazawa T; Tomita Y; Yoshida N; Tomioka A; Horiuchi T; Nagata C; Orihara M; Yamada MH; Saito S
    BMC Anesthesiol; 2014; 14():92. PubMed ID: 25349529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of rocuronium-induced neuromuscular block with sugammadex and resulting histopathological effects in rat kidneys.
    Bostan H; Kalkan Y; Tomak Y; Tumkaya L; Altuner D; Yılmaz A; Erdivanli B; Bedir R
    Ren Fail; 2011; 33(10):1019-24. PubMed ID: 22013936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sugammadex on rocuronium induced changes in pancreatic mast cells.
    Kalkan Y; Tumkaya L; Bostan H; Tomak Y; Altuner D; Yilmaz A; Erdivanli B; Bedir R; Yalcin A; Turan A
    Toxicol Ind Health; 2015 Aug; 31(8):738-46. PubMed ID: 23552269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex is cleared rapidly and primarily unchanged via renal excretion.
    Peeters P; Passier P; Smeets J; Zwiers A; de Zwart M; van de Wetering-Krebbers S; van Iersel M; van Marle S; van den Dobbelsteen D
    Biopharm Drug Dispos; 2011 Apr; 32(3):159-67. PubMed ID: 21370235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay.
    de Zwart MA; ten Bruggencate-Broeders J; van Hal HJ; Megens RH; Frasa HW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1573-86. PubMed ID: 21531635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.